Category - New Drug Applications

New Drug Applications

ViiV Healthcare submits New Drug Application to the FDA for Fostemsavir, an Investigational, First-in-Class Attachment Inhibitor for the Treatment of HIV in Adults with Few Treatment Options Available

6 years ago

New Drug Applications

Zogenix Announces FDA Acceptance for Filing of New Drug Application and Priority Review for Fintepla for the Treatment of Dravet Syndrome

6 years ago

New Drug Applications

Sunovion Resubmits New Drug Application for Apomorphine Sublingual Film

6 years ago

New Drug Applications

Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD

6 years ago

New Drug Applications

MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis

6 years ago

New Drug Applications

Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Blepharoptosis (Droopy Eyelid)

6 years ago

New Drug Applications

Evofem Biosciences Resubmits New Drug Application to U.S. FDA for Amphora® for the Prevention of Pregnancy

6 years ago

New Drug Applications

Cassiopea Announces FDA Acceptance of its New Drug Application for Clascoterone Cream 1%

6 years ago

New Drug Applications

Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder

6 years ago

New Drug Applications

Agile Therapeutics Announces FDA Extension of Twirla NDA Review Period

6 years ago